Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 865

1.

Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of acute lung allograft rejection.

Ahya VN, Douglas LP, Andreadis C, Arnoldi S, Svoboda J, Kotloff RM, Hadjiliadis D, Sager JS, Woo YJ, Pochettino A, Schuster SJ, Stadtmauer EA, Tsai DE.

J Heart Lung Transplant. 2007 Aug;26(8):839-44.

PMID:
17692789
2.

Epstein-Barr virus load in whole blood is associated with immunosuppression, but not with post-transplant lymphoproliferative disease in stable adult heart transplant patients.

Doesch AO, Konstandin M, Celik S, Kristen A, Frankenstein L, Sack FU, Schnabel P, Schnitzler P, Katus HA, Dengler TJ.

Transpl Int. 2008 Oct;21(10):963-71. doi: 10.1111/j.1432-2277.2008.00709.x.

3.

Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.

Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.

J Heart Lung Transplant. 2008 Jan;27(1):100-5. doi: 10.1016/j.healun.2007.09.027.

PMID:
18187094
4.

The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience.

Kogan-Liberman D, Burroughs M, Emre S, Moscona A, Shneider BL.

J Pediatr Gastroenterol Nutr. 2001 Oct;33(4):445-9.

PMID:
11698761
5.

[Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].

Merlino C, Giacchino F, Bergallo M, Bonello F, Bollero C, Segoloni GP, Cavallo R.

G Ital Nefrol. 2003 Mar-Apr;20(2):170-5. Italian.

PMID:
12746803
6.

Posttransplant lymphoproliferative disorder in liver allograft biopsies: a comparison of three methods for the demonstration of Epstein-Barr virus.

Lones MA, Shintaku IP, Weiss LM, Thung SN, Nichols WS, Geller SA.

Hum Pathol. 1997 May;28(5):533-9.

PMID:
9158700
7.

Epstein-Barr virus-DNA load monitoring late after lung transplantation: a surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression.

Bakker NA, Verschuuren EA, Erasmus ME, Hepkema BG, Veeger NJ, Kallenberg CG, van der Bij W.

Transplantation. 2007 Feb 27;83(4):433-8.

PMID:
17318076
8.

Acute cellular rejection and Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a pediatric lung transplant with low viral load.

Calabrese F, Loy M, Lunardi F, Marino D, Aversa SM, Rea F.

Transpl Infect Dis. 2010 Aug 1;12(4):342-6. doi: 10.1111/j.1399-3062.2009.00487.x.

PMID:
20030794
9.

EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: results of a two-arm prospective trial.

Tsai DE, Douglas L, Andreadis C, Vogl DT, Arnoldi S, Kotloff R, Svoboda J, Bloom RD, Olthoff KM, Brozena SC, Schuster SJ, Stadtmauer EA, Robertson ES, Wasik MA, Ahya VN.

Am J Transplant. 2008 May;8(5):1016-24. doi: 10.1111/j.1600-6143.2008.02183.x.

10.

Response of elevated Epstein-Barr virus DNA levels to therapeutic changes in pediatric liver transplant patients: 56-month follow up and outcome.

Holmes RD, Orban-Eller K, Karrer FR, Rowe DT, Narkewicz MR, Sokol RJ.

Transplantation. 2002 Aug 15;74(3):367-72.

PMID:
12177616
11.

Epstein Barr viral load monitoring by quantitative PCR in renal transplant patients.

Merlino C, Cavallo R, Bergallo M, Giacchino F, Bollero C, Negro Ponzi A, Cavallo G.

New Microbiol. 2003 Apr;26(2):141-9.

PMID:
12737195
12.

Epstein-Barr viral infection in renal allograft recipients: a single center experience.

Zadeh ZR, Makhdumi K, Lak SS.

Saudi J Kidney Dis Transpl. 2006 Sep;17(3):351-4.

13.

Low-dose immunosuppression reduces the incidence of post-transplant lymphoproliferative disease in pediatric liver graft recipients.

Ganschow R, Schulz T, Meyer T, Broering DC, Burdelski M.

J Pediatr Gastroenterol Nutr. 2004 Feb;38(2):198-203.

PMID:
14734884
15.

Use of EBV PCR for the diagnosis and monitoring of post-transplant lymphoproliferative disorder in adult solid organ transplant patients.

Tsai DE, Nearey M, Hardy CL, Tomaszewski JE, Kotloff RM, Grossman RA, Olthoff KM, Stadtmauer EA, Porter DL, Schuster SJ, Luger SM, Hodinka RL.

Am J Transplant. 2002 Nov;2(10):946-54.

16.

Monitoring of Epstein-Barr virus load and killer T cells in pediatric renal transplant recipients.

Sato T, Fujieda M, Maeda A, Tanaka E, Miyamura M, Chikamoto H, Hisano M, Akioka Y, Ishiura Y, Dohno S, Hattori M, Wakiguchi H.

Clin Nephrol. 2008 Nov;70(5):393-403.

PMID:
19000539
17.

Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression.

Ellis D, Jaffe R, Green M, Janosky JJ, Lombardozzi-Lane S, Shapiro R, Scantlebury V, Vivas C, Jordan ML.

Transplantation. 1999 Oct 15;68(7):997-1003.

PMID:
10532541
18.

Detection of Epstein-Barr virus DNA in peripheral blood is associated with the development of bronchiolitis obliterans syndrome after lung transplantation.

Engelmann I, Welte T, F├╝hner T, Simon AR, Mattner F, Hoy L, Schulz TF, Gottlieb J.

J Clin Virol. 2009 May;45(1):47-53. doi: 10.1016/j.jcv.2009.02.005.

PMID:
19303808
19.

Semiquantitative PCR analysis of Epstein-Barr virus DNA in clinical samples of patients with EBV-associated diseases.

Meerbach A, Gruhn B, Egerer R, Reischl U, Zintl F, Wutzler P.

J Med Virol. 2001 Oct;65(2):348-57.

PMID:
11536243
20.

A prospective study in heart and lung transplant recipients correlating persistent Epstein-Barr virus infection with clinical events.

Haque T, Thomas JA, Parratt R, Hunt BJ, Yacoub MH, Crawford DH.

Transplantation. 1997 Oct 15;64(7):1028-34.

PMID:
9381525

Supplemental Content

Support Center